Janssen’s AdVac® technology

587   3 years ago
587   3 years ago
For more than 20 years, Johnson & Johnson has invested in vaccine capabilities. Our approach to the research and development of vaccines fuses a start-up mindset with deep scientific expertise to prevent some of the most life-threatening infectious diseases.

Share on Social:

Facebook Post on X Whatsapp LinkedIn Instagram Email
Please log in or register to post comments